Translations:Sulfonylurea/23/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
FuzzyBot (talk | contribs)
Importing a new version from external source
 
(No difference)

Latest revision as of 20:35, 12 March 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Sulfonylurea)
===Classification===
Sulfonylureas are divided into 3 classes on basis of therapeutic efficiency of their antidiabetic action:
* First-generation drugs:
They include [[acetohexamide]], [[carbutamide]], [[chlorpropamide]], [[glycyclamide]] (tolcyclamide), [[metahexamide]], [[tolazamide]] and [[tolbutamide]].
* Second-generation drugs:
They include [[glibenclamide]] (glyburide), [[glibornuride]], [[gliclazide]], [[glipizide]], [[gliquidone]], [[glisoxepide]] and [[glyclopyramide]].
* Third-generation drugs:
They include [[glimepiride]], although it is sometimes considered a second-generation drug.
===Mechanism of action===
[[File:Glucose Insulin Release Pancreas.svg|thumb|Diagram of glucose reduction and insulin release in the pancreas]]

Classification

Sulfonylureas are divided into 3 classes on basis of therapeutic efficiency of their antidiabetic action:

  • First-generation drugs:

They include acetohexamide, carbutamide, chlorpropamide, glycyclamide (tolcyclamide), metahexamide, tolazamide and tolbutamide.

  • Second-generation drugs:

They include glibenclamide (glyburide), glibornuride, gliclazide, glipizide, gliquidone, glisoxepide and glyclopyramide.

  • Third-generation drugs:

They include glimepiride, although it is sometimes considered a second-generation drug.

Mechanism of action

Diagram of glucose reduction and insulin release in the pancreas